SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-614565
Filing Date
2016-06-07
Accepted
2016-06-07 06:07:08
Documents
3
Period of Report
2016-06-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d203286d8k.htm 8-K 14778
2 EX-99.1 d203286dex991.htm EX-99.1 247105
3 GRAPHIC g203286g20l42.jpg GRAPHIC 11519
  Complete submission text file 0001193125-16-614565.txt   273837
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161699929
SIC: 2834 Pharmaceutical Preparations